Alterity Therapeutics (ATHE) said on Monday it appointed Abby Niven to succeed Phillip Hains as chief financial officer, effective today.
Niven has extensive experience in private wealth management with groups including ANZ, UBS and Ord Minett and consults on governance, finance, and corporate structure for various companies.
Hains continues as company secretary.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。